MGA GUIDED INTENSIVE INDUCTION WITH HIGH DOSE CYTARABINE PLUS IDARUBICIN IN 149 AML ELDERLY PATIENTS

被引：0
|
作者：
Capelli, D. [1 ]
Saraceni, F. [1 ]
Chiarucci, M. [1 ]
Poloni, A. [1 ]
Discepoli, G. [2 ]
Leoni, P. [1 ]
Olivieri, A. [1 ]
机构：
[1] Osped Riuniti Ancona, Dept Haematol, Torrette Di Ancona, Italy
[2] Osped Salesi, Dept Cytogenet, Torrette Di Ancona, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P190
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] Efficacy and Feasibility of High-Dose Cytarabine Plus Idarubicin and Amifostine As Induction Schedule: A Prospective Observational Study of 100 AML Elderly Fit Patients
    Capelli, Debora
    Chiarucci, Martina
    Saraceni, Francesco
    Poloni, Antonella
    Montanari, Mauro
    Offidani, Massimo
    Rupoli, Serena
    Scortechini, Anna Rita
    Gini, Guido
    Scortechini, Ilaria
    Leoni, Pietro
    Olivieri, Attilio
    BLOOD, 2012, 120 (21)
  • [2] High dose idarubicin (HIda) with high dose cytarabine (HiDac) as induction therapy for newly diagnosed patients with AML.
    Maslak, P
    Weiss, M
    Jurcic, J
    Jimenez, J
    Berman, E
    Golde, D
    Scheinberg, D
    BLOOD, 1998, 92 (10) : 231A - 231A
  • [3] Intensive chemotherapy with idarubicin, cytarabine and G-CSF in elderly patients with acute myelogenous leukemia (AML)
    Chaibi, P
    Dombret, H
    Rousselot, P
    Gardin, C
    Glaisner, S
    Castaigne, S
    Degos, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 822 - 822
  • [4] Remission induction with cladribine, cytarabine and idarubicin (CAI) in elderly patients with relapsed AML - A pilot study.
    von Lilienfeld-Toal, Marie
    Hahn-Ast, Corinna
    Orlopp, Katjana
    Ingo, Schmidt-Wolf G. H.
    Axel, Glasmacher
    BLOOD, 2006, 108 (11) : 222B - 222B
  • [5] Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly AML or High Risk MDS Patients
    Gardner, Kelda
    Estey, Elihu H.
    Tong, Weigang
    McCroskey, Robert
    Walter, Roland B.
    Hendrie, Paul C.
    Scott, Bart L.
    Perdue, Andrea M.
    Percival, Mary-Elizabeth M.
    Smith, Heather A.
    Hammer, Cody
    Becker, Pamela S.
    BLOOD, 2016, 128 (22)
  • [6] Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients
    Takahashi, Koichi
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Kadia, Tapan
    DiNardo, Courtney
    Jabbour, Elias
    Pierce, Sherry
    Estrov, Zeev
    Konopleva, Marina
    Andreeff, Michael
    Ravandi, Farhad
    Cortes, Jorge
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (03): : 163 - 168
  • [7] Induction chemotherapy with high-dose cytarabine and mitoxantrone in elderly acute myeloid leukemia (AML) patients.
    Ramanathan, Muthalagu
    Cerny, Jan
    Raffel, Glen
    Walsh, William Vincent
    Woda, Bruce
    Miron, Patricia
    Nath, Rajneesh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Idarubicin, high-dose cytarabine and etoposide for remission induction in patients with relapsed acute leukemia
    Mehta, J
    Powles, R
    Singhal, S
    Horton, C
    Prediville, J
    Glynne, P
    Zomas, A
    Hamblin, S
    Saso, R
    Mackay, H
    Treleaven, J
    BLOOD, 1995, 86 (10) : 2041 - 2041
  • [9] Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemia
    Mehta, J
    Powles, R
    Singhal, S
    Horton, C
    Hamblin, M
    Zomas, A
    Saso, R
    Prendiville, J
    Glynne, P
    Allford, S
    Mackay, H
    Treleaven, J
    SEMINARS IN HEMATOLOGY, 1996, 33 (04) : 18 - 23
  • [10] Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high-dose cytarabine and idarubicin
    Ravandi, Farhad
    Patel, Keyur
    Luthra, Rajyalakshmi
    Faderl, Stefan
    Konopleva, Marina
    Kadia, Tapan
    Brandt, Mark
    Pierce, Sherry
    Kornblau, Steven
    Andreeff, Michael
    Wang, Xuemei
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Kantarjian, Hagop
    CANCER, 2012, 118 (10) : 2665 - 2673
12345